André-Michel Ballester

Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy.

IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485.

Bomi Italia SpA is a holding company, which engages in the logistics and management of high-technology products for health protection. The company manages the storage and distribution of medical devices, pharmaceuticals, products for in-vitro diagnostics, reagents, and implantable products for dialysis. It also provides warehousing, transport management, consignment stock, labeling and kitting, virtual branch, and other special services. The company was founded by Giorgio Ruini in 1985 and is headquartered in Spino d’Adda, Italy.